All Stories

  1. Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH

    Article • Liver International, February 2020, Wiley

    PhD Francesca Virginia Bruschi

  2. Monoacylglycerol lipase inhibition protects from liver injury in mouse models of sclerosing cholangitis

    Article • Hepatology, September 2019, Wiley

    PhD Francesca Virginia Bruschi

  3. I148M PNPLA3 hepatic stellate cells display lower LXR activity compared to wt PNPLA3

    Article • Hepatology Communications, July 2019, Wiley

    PhD Francesca Virginia Bruschi

  4. Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorption

    Article • Journal of Lipid Research, May 2019, American Society for Biochemistry & Molecular Biology (ASBMB)

    PhD Francesca Virginia Bruschi

  5. Nuclear Receptor Regulation of Aquaglyceroporins in Metabolic Organs

    Article • International Journal of Molecular Sciences, June 2018, MDPI AG

    PhD Francesca Virginia Bruschi

  6. PNPLA3 I148M by disrupting PPAR gamma signaling regulates aquaporin 3 in stellate cells

    Article • Scientific Reports, November 2017, Nature

    thierry claudel, PhD Francesca Virginia Bruschi

  7. how PNPLA3 polymorphism impacts on liver homeostasis

    Article • Hepatic Medicine Evidence and Research, November 2017, Dove Medical Press

    PhD Francesca Virginia Bruschi, thierry claudel

  8. adiponectin by regulating PPAR alpha activity regulates aquaporin 3 in HSC

    Article • Biochemical and Biophysical Research Communications, August 2017, Elsevier

    thierry claudel, PhD Francesca Virginia Bruschi

  9. PNPLA3 mutant lowers PPARg signaling in HSC

    Article • Hepatology, April 2017, Wiley

    PhD Francesca Virginia Bruschi, thierry claudel, Fabio Marra